Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Predicted Market Size Of The Opioid Use Disorder (OUD) Industry By 2029?

The market size for opioid use disorder (oud) has been expanding at a quick pace in recent times. Projected to rise from $3.96 billion in 2024 to $4.37 billion in 2025, it experiences a compound annual growth rate (CAGR) of 10.5%. The growth observed in the historic phase is due to factors such as heightened prescription rates, methods of pain management, drug promotion, and the social stigma associated with addiction.

Expectations are high for the rapid expansion of the opioid use disorder (oud) market in the coming years. The market is projected to reach a value of $6.91 billion in 2029, experiencing a compound annual growth rate (CAGR) of 12.1%. Regulatory measures, increased emphasis on alternative pain management, wider access to treatment, and public health initiatives are all substantial contributors to the anticipated growth during the forecast period. Key trends expected during this timeframe include tech-based treatment innovations, personalized treatment strategies, cohesive care models, community-level support initiatives, and emphasis on early intervention and prevention.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

Which Factors Are Steering Growth In The Opioid Use Disorder (OUD) Market?

The escalation in opioid addiction instances is anticipated to fuel the expansion of the opioid use disorder (OUD) market in the future. Opioid addiction denotes a medical situation marked by habitual and obsessive opioid intake that has detrimental consequences on the body. Opioids can induce a feeling of extreme happiness and alleviate pain, persistent use of which may result in the build-up of tolerance, necessitating larger doses to attain the same outcome, possibly leading to opioid use disorder. For example, the Centers for Disease Control and Prevention, a public health organization based in the US, reported in March 2024 that the synthetic opioid drug overdose rate surged by 4.1%, escalating from 21.8 to 22.7 between 2021 and 2022. Hence, the rising number of opioid addiction instances bolsters the growth of the opioid use disorder (OUD) market.

Which Segment Accounts For The Largest Share In The Opioid Use Disorder (OUD) Market?

The opioid use disorder (oud)market covered in this report is segmented –

1) By Drug Type: Buprenorphine; Naltrexone; Methadone

2) By Route of Administration: Oral; Parenteral

3) By Age Group: 19 To 40; 41 To 60; 61 And Over

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies And Stores; Online Pharmacies

Subsegments:

1) By Buprenorphine: Suboxone; Buprenorphine Tablets; Buprenorphine Film

2) By Naltrexone: Naltrexone Tablets; Vivitrol

3) By Methadone: Methadone Tablets; Methadone Oral Solution

Which Long-Term Trends Will Play A Crucial Role In The Opioid Use Disorder (OUD) Market?

The rising trend of product innovation is significantly shaping the market for opioid use disorder (OUD). Preeminent companies in the OUD market are continually introducing novel products to maintain and strengthen their market standing. For example, in May 2023, Brixadi (buprenorphine) extended-release injection, an innovative product for the treatment of moderate to severe OUD, secured approval from the U.S. Food and Drug Administration, a federal agency in the US. Brixadi is offered in two distinct dosage forms. One is a weekly injection suitable for patients who have started their treatment with a solitary dose of a transmucosal buprenorphine product or are on the medication currently, and the other is a monthly alternative for patients already on the prescribed medication.

Who Are The Dominant Players In The Opioid Use Disorder (OUD) Market Today?

Major companies operating in the opioid use disorder (OUD) market include Pfizer Inc., Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Chiesi Pharmaceuticals S.p.A., Hikma Pharmaceuticals Plc., Mallinckrodt Pharmaceuticals, Indivior Plc., Purdue Pharma L.P, Alkermes Inc., Collegium Pharmaceutical Inc., Vanda Pharmaceuticals Inc., Camurus AB, Tris Pharma Inc., Mylan NV., Orexo US Inc., Zogenix Inc., Rhodes Pharmaceuticals L.P., Omeros Corporation, Braeburn Pharmaceuticals Inc., Adapt Pharma Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., AcelRx Pharmaceuticals Inc., KemPharm Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

What Regional Factors Are Accelerating Growth In The Opioid Use Disorder (OUD) Market?

North America was the largest region in the opioid use disorder (OUD) market in 2024. The regions covered in the opioid use disorder (OUD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12586&type=smp

Browse Through More Reports Similar to the Global Opioid Use Disorder (OUD) Market 2025, By The Business Research Company

Used Truck Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/used-truck-global-market-report

Used Cars Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/used-cars-global-market-report

Non Opioid Pain Patch Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/non-opioid-pain-patch-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model